ILiAD Biotechnologies Announces Presentation of Positive Phase 2b Data for Next Generation Pertussis Vaccine at World Vaccine Congress

NEXT STORY
Spero Therapeutics Hosting Key Opinion Leader Call on Oral Tebipenem HBr for the Treatment of Complicated Urinary Tract Infections
PREV STORY
Inovalon Launches the Inovalon DataStream™ API
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

STRATA Skin Sciences Announces: Expanding Medical Coverage for Excimer Laser Treatment of Dermatological Conditions, Enlarging Company’s Addressable Market

author_avatar
NASDAQ Market News

Lumenis Expands Its Portfolio of Gynecology Solutions With the New UltraPulse(R) DUO(TM) for Fertility-Related Disorders and FemTouch(TM) for Improved Vaginal Health

LAS VEGAS, Nov. 13, 2015 (GLOBE NEWSWIRE) -- Lumenis Ltd., the world's largest energy-based ...

author_avatar
NASDAQ Market News

TRACON Pharmaceuticals Presents Positive Clinical Data from TRC105 and TRC102 Studies at American Society of Clinical Oncology (ASCO) 2017 Annual Meeting

Identified Biomarkers that Correlate with Response in Renal Cell Carcinoma and Soft Tissue Sarcoma ...

author_avatar
NASDAQ Market News